Clinical trial
Clinical Trial of the Use of Ketamine in Treatment Resistant Depression
NCT02610712 is registered in ClinicalTrials.gov with National Institute of Neurology and Neurosurgery, Mexico as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Trial of the Use of Ketamine in Treatment Resistant Depression
- Lead sponsor
- National Institute of Neurology and Neurosurgery, Mexico
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- May 31, 2014
- Completion date
- Not reported
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.